Are ‘Professional Patients’ in Clinical Trials an Epidemic?
So-called “professional patients” threaten the integrity of clinical trials, but can they be stopped?
Cannabis Clinical Trials Struggle to Gain Momentum in the US
Medical marijuana trials are stalled in the US, but here’s how sponsors and CROs can be ready when those trials are finally possible.
Will Direct-to-Patient Clinical Trials Solve the Patient Retention Problem?
Direct-to-patient clinical trials may offer a solution for patient enrollment and retention woes.
Increasing African-American Enrollment in Clinical Trials through Holistic Recruitment
African-Americans are underrepresented in many clinical trials. Here are three steps CROs and sponsors can take to improve recruitment of minority patients.
Struggling to Convert New Patients? 5 Steps to Facebook Ad Success for Clinical Trials
Many clinical trials fail to convert patients using Facebook Ads. From ad design to audience targeting, here’s how to drive higher patient recruitment rates in five simple steps.
FDA’s MyStudies App Marks a Milestone for Mobile Data in Clinical Trials
The FDA’s new healthcare app takes a patient-centric approach to collecting data for clinical trials.
Use Search and Social Media Ads to Recruit Patients for Rare Disease Clinical Trials
Meeting recruitment goals is incredibly challenging for any clinical trial, but it’s even more so when fewer than 200,000 people nationwide are potential candidates, as is often the case for rare disease studies.
New Click-to-Text Capabilities in Google Ads Offer Exciting Opportunities for Clinical Trials
Google’s new click-to-message ad feature will offer a new means for clinical trials to connect with potential patients.
Report: Patients Know the Value of Clinical Trials, But Not How to Get Involved
A new study reveals that patients want to participate in clinical trials, but few discuss clinical research with their doctors. Fortunately, digital channels offer sponsors and CROs a direct line to patients searching for treatment options.
